We previously defined a signaling pathway-based gene signature named the RKIP pathway metastasis signature (RPMS) that is predictive for metastasis-free survival in a heterogeneous cohort of breast cancer patients [13]–[15]. Here, PEBP1 is linked to breast carcinoma.